R. Schneppenheim and U. Budde, Phenotypic and genotypic diagnosis of von Willebrand disease: A 2004 update, Seminars in Hematology, vol.42, issue.1, pp.15-28, 2005.
DOI : 10.1053/j.seminhematol.2004.10.002

R. Schneppenheim and U. Budde, von Willebrand factor: the complex molecular genetics of a multidomain and multifunctional protein, Journal of Thrombosis and Haemostasis, vol.8, issue.Pt 1, pp.209-224, 2011.
DOI : 10.1111/j.1538-7836.2011.04324.x

J. Rayes, A. Hommais, P. Legendre, H. Tout, A. Veyradier et al., Effect of von Willebrand disease type 2B and type 2M mutations on the susceptibility of von Willebrand factor to ADAMTS-13, Journal of Thrombosis and Haemostasis, vol.101, issue.2, pp.321-329, 2007.
DOI : 10.1111/j.1538-7836.2007.02296.x

A. Federici, P. Mannucci, G. Castaman, L. Baronciani, P. Bucciarelli et al., Clinical and molecular predictors of thrombocytopenia and risk of bleeding in patients with von Willebrand disease type 2B: a cohort study of 67 patients, Blood, vol.113, issue.3, pp.526-560, 2009.
DOI : 10.1182/blood-2008-04-152280

J. Rayes, M. Hollestelle, P. Legendre, I. Marx, P. De-groot et al., Mutation and ADAMTS13-dependent modulation of disease severity in a mouse model for von Willebrand disease type 2B, Blood, vol.115, issue.23, pp.4870-4877, 2010.
DOI : 10.1182/blood-2009-11-254193

M. Nishino, J. Girma, C. Rothschild, E. Fressinaud, and D. Meyer, New variant of von Willebrand disease with defective binding to factor VIII, Blood, vol.74, pp.1591-1600, 1989.

V. Flood, C. Lederman, J. Wren, P. Christopherson, K. Friedman et al., Absent collagen binding in a VWF A3 domain mutant: utility of the VWF:CB in diagnosis of VWD, Journal of Thrombosis and Haemostasis, vol.91, issue.6, pp.1431-1434, 2010.
DOI : 10.1111/j.1538-7836.2010.03869.x

A. Ribba, I. Loisel, J. Lavergne, I. Juhan-vague, B. Obert et al., Ser968Thr mutation within the A3 domain of von Willebrand factor (VWF) in two related patients leads to a defective binding of VWF to collagen, Thromb Haemost, vol.86, pp.848-54, 2001.

A. Riddell, K. Gomez, C. Millar, G. Mellars, S. Gill et al., Characterization of W1745C and S1783A: 2 novel mutations causing defective collagen binding in the A3 domain of von Willebrand factor, Blood, vol.114, issue.16, pp.3489-96, 2009.
DOI : 10.1182/blood-2008-10-184317

I. Marx, O. Christophe, P. Lenting, A. Rupin, M. Vallez et al., Altered thrombus formation in von Willebrand factor-deficient mice expressing von Willebrand factor variants with defective binding to collagen or GPIIbIIIa, Blood, vol.112, issue.3, pp.603-612, 2008.
DOI : 10.1182/blood-2008-02-142943

A. Casonato, E. Pontara, F. Sartorello, M. Cattini, M. Sartori et al., Reduced von Willebrand factor survival in type Vicenza von Willebrand disease, Blood, vol.99, issue.1, pp.180-184, 2002.
DOI : 10.1182/blood.V99.1.180

P. Lenting, E. Westein, V. Terraube, A. Ribba, E. Huizinga et al., An Experimental Model to Study the in Vivo Survival of von Willebrand Factor: BASIC ASPECTS AND APPLICATION TO THE R1205H MUTATION, Journal of Biological Chemistry, vol.279, issue.13, pp.12102-12111, 2004.
DOI : 10.1074/jbc.M310436200

C. Pruss, M. Golder, A. Bryant, C. Hegadorn, E. Burnett et al., Pathologic mechanisms of type 1 VWD mutations R1205H and Y1584C through in vitro and in vivo mouse models, Blood, vol.117, issue.16, pp.4358-66, 2011.
DOI : 10.1182/blood-2010-08-303727

C. Denis, O. Christophe, B. Oortwijn, and P. Lenting, Clearance of von Willebrand factor, Thrombosis and Haemostasis, vol.99, pp.271-279, 2008.
DOI : 10.1160/TH07-10-0629
URL : https://hal.archives-ouvertes.fr/inserm-00260376

S. Haberichter, G. Castaman, U. Budde, I. Peake, A. Goodeve et al., Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD), Blood, vol.111, issue.10
DOI : 10.1182/blood-2007-09-110940

C. Van-schooten, P. Tjernberg, E. Westein, V. Terraube, G. Castaman et al., Cysteine-mutations in von Willebrand factor associated with increased clearance, Journal of Thrombosis and Haemostasis, vol.96, issue.10, pp.2228-2265, 2005.
DOI : 10.1111/j.1538-7836.2005.01571.x

A. Federici, P. Bucciarelli, G. Castaman, L. Baronciani, M. Canciani et al., on Willebrand Disease in Italy: Results from the Retrospective Study on 1234 Patients, Seminars in Thrombosis and Hemostasis, vol.37, issue.05, pp.511-532, 2011.
DOI : 10.1055/s-0031-1281037

G. Castaman, A. Tosetto, A. Federici, and F. Rodeghiero, Bleeding tendency and efficacy of anti-haemorrhagic treatments in patients with type 1 von Willebrand disease and increased von Willebrand factor clearance, Thrombosis and Haemostasis, vol.105, issue.4, pp.647-54, 2011.
DOI : 10.1160/TH10-11-0697

S. Shetty, P. Kasatkar, and K. Ghosh, Pathophysiology of acquired von Willebrand disease: a concise review, European Journal of Haematology, vol.67, issue.2, pp.99-106, 2011.
DOI : 10.1111/j.1600-0609.2011.01636.x

A. Tiede, J. Rand, U. Budde, A. Ganser, and A. Federici, How I treat the acquired von Willebrand syndrome, Blood, vol.117, issue.25, pp.6777-85, 2011.
DOI : 10.1182/blood-2010-11-297580

U. Budde, R. Scharf, P. Franke, K. Hartmann-budde, J. Dent et al., Elevated platelet count as a cause of abnormal von Willebrand factor multimer distribution in plasma, Blood, vol.82, pp.1749-57, 1993.

C. Richard, M. Cuadrado, M. Prieto, J. Batlle, L. Fernandez et al., Acquired von willebrand disease in multiple myeloma secondary to absorption of von willebrand factor by plasma cells, American Journal of Hematology, vol.138, issue.2, pp.114-121, 1990.
DOI : 10.1002/ajh.2830350210

J. Gill, A. Wilson, J. Endres-brooks, and R. Montgomery, Loss of the largest von Willebrand factor multimers from the plasma of patients with congenital cardiac defects, Blood, vol.67, pp.758-61, 1986.

T. Warkentin, J. Moore, and D. Morgan, Aortic stenosis and bleeding gastrointestinal angiodysplasia: is acquired von Willebrand's disease the link?, The Lancet, vol.340, issue.8810, pp.35-42, 1992.
DOI : 10.1016/0140-6736(92)92434-H

A. Vincentelli, S. Susen, L. Tourneau, T. Six, I. Fabre et al., Acquired von Willebrand Syndrome in Aortic Stenosis, New England Journal of Medicine, vol.349, issue.4, pp.343-352, 2003.
DOI : 10.1056/NEJMoa022831

A. Banerjee, Angiodysplasia associated with hypertrophic obstructive cardiomyopathy (HOCM), Br J Clin Pract, vol.44, pp.326-333, 1990.

L. Tourneau, T. Susen, S. Caron, C. Millaire, A. Marechaux et al., Functional Impairment of Von Willebrand Factor in Hypertrophic Cardiomyopathy: Relation to Rest and Exercise Obstruction, Circulation, vol.118, issue.15, pp.1550-1557, 2008.
DOI : 10.1161/CIRCULATIONAHA.108.786681

M. Slaughter, Hematologic Effects of Continuous Flow Left Ventricular Assist Devices, Journal of Cardiovascular Translational Research, vol.50, issue.5, pp.618-642, 2010.
DOI : 10.1007/s12265-010-9222-6

F. Pareti, A. Lattuada, C. Bressi, M. Zanobini, A. Sala et al., Proteolysis of von Willebrand Factor and Shear Stress-Induced Platelet Aggregation in Patients With Aortic Valve Stenosis, Circulation, vol.102, issue.11, pp.1290-1295, 2000.
DOI : 10.1161/01.CIR.102.11.1290

X. Zhang, K. Halvorsen, C. Zhang, W. Wong, and T. Springer, Mechanoenzymatic Cleavage of the Ultralarge Vascular Protein von Willebrand Factor, Science, vol.324, issue.5932, pp.1330-1334, 2009.
DOI : 10.1126/science.1170905

M. Van-schie, J. Van-loon, M. De-maat, and F. Leebeek, Genetic determinants of von Willebrand factor levels and activity in relation to the risk of cardiovascular disease: a review, Journal of Thrombosis and Haemostasis, vol.115, issue.2967, pp.899-908, 2011.
DOI : 10.1111/j.1538-7836.2011.04243.x

D. Meyer, S. , D. Maeyer, B. Deckmyn, H. Vanhoorelbeke et al., Von Willebrand Factor: Drug and Drug Target, Cardiovascular & Hematological Disorders-Drug Targets, vol.9, issue.1, pp.9-20, 2009.
DOI : 10.2174/187152909787581327

A. Jager, V. Van-hinsbergh, P. Kostense, J. Emeis, J. Yudkin et al., von Willebrand Factor, C-Reactive Protein, and 5-Year Mortality in Diabetic and Nondiabetic Subjects : The Hoorn Study, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.19, issue.12, pp.3071-3079, 1999.
DOI : 10.1161/01.ATV.19.12.3071

B. Wiman, T. Andersson, J. Hallqvist, C. Reuterwall, and A. Ahlbom, Plasma Levels of Tissue Plasminogen Activator/Plasminogen Activator Inhibitor-1 Complex and von Willebrand Factor Are Significant Risk Markers for Recurrent Myocardial Infarction in the Stockholm Heart Epidemiology Program (SHEEP) Study, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.20, issue.8, pp.2019-2042, 2000.
DOI : 10.1161/01.ATV.20.8.2019

T. Klemm, A. Mehnert, A. Siegemund, T. Wiesner, G. Gelbrich et al., Impact of the Thr789Ala Variant of the von Willebrand Factor Levels, on Ristocetin Co-Factor and Collagen Binding Capacity and its Association with Coronary Heart Disease in Patients With Diabetes Mellitus Type 2, Experimental and Clinical Endocrinology & Diabetes, vol.113, issue.10, pp.568-72, 2005.
DOI : 10.1055/s-2005-872896

C. Lacquemant, C. Gaucher, C. Delorme, G. Chatellier, Y. Gallois et al., Association between high von Willebrand factor levels and the Thr789Ala vWF gene polymorphism but not with nephropathy in type I diabetes, Kidney International, vol.57, issue.4, pp.1437-1480, 2000.
DOI : 10.1046/j.1523-1755.2000.00988.x

I. Van-der-meer, G. Brouwers, S. Bulk, F. Leebeek, D. Van-der-kuip et al., Genetic variability of von Willebrand factor and risk of coronary heart disease: the Rotterdam Study, British Journal of Haematology, vol.98, issue.3, pp.343-350, 2004.
DOI : 10.1006/geno.1994.1241

N. Smith, K. Rice, E. Bovill, M. Cushman, J. Bis et al., Genetic variation associated with plasma von Willebrand factor levels and the risk of incident venous thrombosis, Blood, vol.117, issue.22, pp.6007-6018, 2011.
DOI : 10.1182/blood-2010-10-315473

G. Antoni, T. Oudot-mellakh, A. Dimitromanolakis, M. Germain, W. Cohen et al., Combined analysis of three genome-wide association studies on vWF and FVIII plasma levels, BMC Medical Genetics, vol.281, issue.Suppl 1, p.102, 2011.
DOI : 10.1074/jbc.M603100200
URL : https://hal.archives-ouvertes.fr/inserm-00617599

N. Smith, M. Chen, A. Dehghan, D. Strachan, S. Basu et al., Novel Associations of Multiple Genetic Loci With Plasma Levels of Factor VII, Factor VIII, and von Willebrand Factor: The CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium, Circulation, vol.121, issue.12, pp.1382-92, 2010.
DOI : 10.1161/CIRCULATIONAHA.109.869156

J. Van-loon, F. Leebeek, J. Deckers, D. Dippel, D. Poldermans et al., Effect of Genetic Variations in Syntaxin-Binding Protein-5 and Syntaxin-2 on von Willebrand Factor Concentration and Cardiovascular Risk, Circulation: Cardiovascular Genetics, vol.3, issue.6, pp.507-519, 2010.
DOI : 10.1161/CIRCGENETICS.110.957407

T. Koster, A. Blann, E. Briet, J. Vandenbroucke, and F. Rosendaal, Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis, The Lancet, vol.345, issue.8943, pp.152-157, 1995.
DOI : 10.1016/S0140-6736(95)90166-3

A. Tsai, M. Cushman, W. Rosamond, S. Heckbert, R. Tracy et al., Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE), The American Journal of Medicine, vol.113, issue.8, pp.636-678, 2002.
DOI : 10.1016/S0002-9343(02)01345-1

M. Takahashi, A. Yamashita, S. Moriguchi-goto, K. Marutsuka, Y. Sato et al., Critical role of von Willebrand factor and platelet interaction in venous thromboembolism, Histol Histopathol, vol.24, pp.1391-1399, 2009.

A. Chauhan, J. Kisucka, C. Lamb, W. Bergmeier, and D. Wagner, von Willebrand factor and factor VIII are independently required to form stable occlusive thrombi in injured veins, Blood, vol.109, issue.6, pp.2424-2433, 2007.
DOI : 10.1182/blood-2006-06-028241

T. Fuchs, A. Bhandari, and D. Wagner, Histones induce rapid and profound thrombocytopenia in mice, Blood, vol.118, issue.13, pp.3708-3722, 2011.
DOI : 10.1182/blood-2011-01-332676
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3186342

A. Brill, T. Fuchs, A. Savchenko, G. Thomas, K. Martinod et al., Neutrophil extracellular traps promote deep vein thrombosis in mice, Journal of Thrombosis and Haemostasis, vol.106, issue.Pt 2, 2011.
DOI : 10.1111/j.1538-7836.2011.04544.x

J. Moake, C. Rudy, J. Troll, M. Weinstein, N. Colannino et al., Unusually Large Plasma Factor VIII: von Willebrand Factor Multimers in Chronic Relapsing Thrombotic Thrombocytopenic Purpura, New England Journal of Medicine, vol.307, issue.23, pp.1432-1437, 1982.
DOI : 10.1056/NEJM198212023072306

G. Levy, D. Motto, and D. Ginsburg, ADAMTS13 turns 3, Blood, vol.106, issue.1, pp.11-18, 2005.
DOI : 10.1182/blood-2004-10-4097

J. Crawley, R. De-groot, Y. Xiang, B. Luken, and D. Lane, Unraveling the scissile bond: how ADAMTS13 recognizes and cleaves von Willebrand factor, Blood, vol.118, issue.12, pp.3212-3233, 2011.
DOI : 10.1182/blood-2011-02-306597

P. Lenting, J. Pegon, E. Groot, and P. De-groot, Regulation of von Willebrand factor-platelet interactions, Thrombosis and Haemostasis, vol.104, issue.3, pp.449-55, 2010.
DOI : 10.1160/TH09-11-0777

D. Ceunynck, K. Rocha, S. Feys, H. , D. Meyer et al., Local Elongation of Endothelial Cell-anchored von Willebrand Factor Strings Precedes ADAMTS13 Protein-mediated Proteolysis, Journal of Biological Chemistry, vol.286, issue.42, pp.36361-36368, 2011.
DOI : 10.1074/jbc.M111.271890

S. Schneider, S. Nuschele, A. Wixforth, C. Gorzelanny, A. Alexander-katz et al., Shear-induced unfolding triggers adhesion of von Willebrand factor fibers, Proceedings of the National Academy of Sciences, vol.104, issue.19, pp.7899-903, 2007.
DOI : 10.1073/pnas.0608422104

P. Lenting and G. Rastegarlari, ADAMTS-13: double trouble for von Willebrand factor, Journal of Thrombosis and Haemostasis, vol.113, issue.Suppl 1, pp.2775-2782, 2010.
DOI : 10.1111/j.1538-7836.2010.04124.x

T. Ganderton, M. Berndt, C. Chesterman, and P. Hogg, Hypothesis for control of von Willebrand factor multimer size by intra-molecular thiol-disulphide exchange, Journal of Thrombosis and Haemostasis, vol.269, issue.1, pp.204-210, 2007.
DOI : 10.1111/j.1538-7836.2006.02292.x

Y. Li, H. Choi, Z. Zhou, L. Nolasco, H. Pownall et al., Covalent regulation of ULVWF string formation and elongation on endothelial cells under flow conditions, Journal of Thrombosis and Haemostasis, vol.264, issue.1, pp.1135-1178, 2008.
DOI : 10.1016/0092-8674(88)90511-9

H. Yeh, Z. Zhou, H. Choi, S. Tekeoglu, W. May et al., Disulfide bond reduction of von Willebrand factor by ADAMTS-13, Journal of Thrombosis and Haemostasis, vol.7, issue.12, pp.2778-88, 2010.
DOI : 10.1111/j.1538-7836.2010.04094.x

X. Fu, J. Chen, R. Gallagher, Y. Zheng, D. Chung et al., Shear stress-induced unfolding of VWF accelerates oxidation of key methionine residues in the A1A2A3 region, Blood, vol.118, issue.19, pp.5283-91, 2011.
DOI : 10.1182/blood-2011-01-331074

J. Chen, X. Fu, Y. Wang, M. Ling, B. Mcmullen et al., Oxidative modification of von Willebrand factor by neutrophil oxidants inhibits its cleavage by ADAMTS13, Blood, vol.115, issue.3, pp.706-718, 2010.
DOI : 10.1182/blood-2009-03-213967

S. Lancellotti, D. Filippis, V. Pozzi, N. Peyvandi, F. Palla et al., Formation of methionine sulfoxide by peroxynitrite at position 1606 of von Willebrand factor inhibits its cleavage by ADAMTS-13: A new prothrombotic mechanism in diseases associated with oxidative stress, Free Radical Biology and Medicine, vol.48, issue.3, pp.446-56, 2010.
DOI : 10.1016/j.freeradbiomed.2009.11.020

D. Filippis, V. Lancellotti, S. Maset, F. Spolaore, B. Pozzi et al., Oxidation of Met1606 in von Willebrand Factor is a Risk Factor for Thrombotic and Septic Complications in Chronic Renal Failure, Biochem J, 2011.

J. Hulstein, P. De-groot, K. Silence, A. Veyradier, R. Fijnheer et al., A novel nanobody that detects the gain-of-function phenotype of von Willebrand factor in ADAMTS13 deficiency and von Willebrand disease type 2B, Blood, vol.106, issue.9, pp.3035-3077, 2005.
DOI : 10.1182/blood-2005-03-1153

J. Hulstein, P. Lenting, B. De-laat, R. Derksen, R. Fijnheer et al., ??2-Glycoprotein I inhibits von Willebrand factor dependent platelet adhesion and aggregation, Blood, vol.110, issue.5, pp.1483-91, 2007.
DOI : 10.1182/blood-2006-10-053199

B. De-laat, P. De-groot, R. Derksen, R. Urbanus, K. Mertens et al., Association between beta2-glycoprotein I plasma levels and the risk of myocardial infarction in older men, Blood, vol.114, issue.17, pp.3656-61, 2009.
DOI : 10.1182/blood-2009-03-212910

D. Meyer, S. Stoll, G. Wagner, D. Kleinschnitz, and C. , von Willebrand Factor: An Emerging Target in Stroke Therapy, Stroke, vol.43, issue.2, 2011.
DOI : 10.1161/STROKEAHA.111.628867

C. Kleinschnitz, D. Meyer, S. Schwarz, T. Austinat, M. Vanhoorelbeke et al., Deficiency of von Willebrand factor protects mice from ischemic stroke, Blood, vol.113, issue.15
DOI : 10.1182/blood-2008-09-180695

D. Meyer, S. Schwarz, T. Deckmyn, H. Denis, C. Nieswandt et al., Binding of von Willebrand Factor to Collagen and Glycoprotein Ib??, But Not to Glycoprotein IIb/IIIa, Contributes to Ischemic Stroke in Mice--Brief Report, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.30, issue.10, pp.1949-51, 2010.
DOI : 10.1161/ATVBAHA.110.208918

J. Chen, A. Reheman, F. Gushiken, L. Nolasco, X. Fu et al., N-acetylcysteine reduces the size and activity of von Willebrand factor in human plasma and mice, Journal of Clinical Investigation, vol.121, issue.2, pp.593-603, 2011.
DOI : 10.1172/JCI41062DS1